Have a feature idea you'd love to see implemented?
Let us know!
HCWB HCW Biologics Inc
Price (delayed)
$0.5101
Market cap
$19.29M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.04
Enterprise value
$28.03M
Highlights
HCW Biologics's gross profit has soared by 60% YoY and by 5% from the previous quarter
HCWB's revenue has surged by 60% year-on-year and by 5% since the previous quarter
HCW Biologics's equity has plunged by 172% from the previous quarter and by 122% YoY
The net income has dropped by 105% year-on-year and by 40% since the previous quarter
Key stats
What are the main financial stats of HCWB
Market
Valuations
Earnings
Shares outstanding
37.82M
Market cap
$19.29M
Enterprise value
$28.03M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
15.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
22.93
Revenue
$1.22M
EBIT
-$38.11M
EBITDA
-$37.19M
Free cash flow
-$22.41M
Per share
Balance sheet
Liquidity
EPS
-$1.04
Free cash flow per share
-$0.59
Book value per share
-$0.17
Revenue per share
$0.03
TBVPS
$0.71
Total assets
$26.82M
Total liabilities
$33.12M
Debt
$9.9M
Equity
-$6.3M
Working capital
-$20.83M
Debt to equity
-1.57
Current ratio
0.1
Quick ratio
0.08
Net debt/EBITDA
-0.24
Margins
Efficiency
Dividend
EBITDA margin
-3,041.7%
Gross margin
100%
Net margin
-3,138.2%
Operating margin
-3,040.8%
Return on assets
-126.4%
Return on equity
-385.9%
Return on invested capital
-187.4%
Return on capital employed
-1,058.4%
Return on sales
-3,117.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HCWB stock price
How has the HCW Biologics stock price performed over time
Intraday
-8.09%
1 week
-14.98%
1 month
-13.91%
1 year
-71.5%
YTD
-58.53%
QTD
-5.43%
Financial performance
How have HCW Biologics's revenue and profit performed over time
Revenue
$1.22M
Gross profit
$1.22M
Operating income
-$37.18M
Net income
-$38.37M
Gross margin
100%
Net margin
-3,138.2%
The net income has dropped by 105% year-on-year and by 40% since the previous quarter
The operating income has dropped by 90% year-on-year and by 33% since the previous quarter
HCW Biologics's gross profit has soared by 60% YoY and by 5% from the previous quarter
HCWB's revenue has surged by 60% year-on-year and by 5% since the previous quarter
Growth
What is HCW Biologics's growth rate over time
Valuation
What is HCW Biologics stock price valuation
P/E
N/A
P/B
N/A
P/S
15.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
22.93
HCWB's EPS has dropped by 96% year-on-year and by 37% since the previous quarter
HCW Biologics's equity has plunged by 172% from the previous quarter and by 122% YoY
HCWB's price to sales (P/S) is 75% less than its last 4 quarters average of 68.3
HCWB's revenue has surged by 60% year-on-year and by 5% since the previous quarter
Efficiency
How efficient is HCW Biologics business performance
The ROE has dropped by 163% since the previous quarter
HCWB's return on invested capital has dropped by 77% since the previous quarter
The ROA has shrunk by 55% QoQ
HCWB's ROS is down by 33% since the previous quarter and by 29% year-on-year
Dividends
What is HCWB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HCWB.
Financial health
How did HCW Biologics financials performed over time
HCWB's total assets is 19% smaller than its total liabilities
HCW Biologics's quick ratio has shrunk by 98% YoY and by 79% QoQ
The company's current ratio has shrunk by 98% YoY and by 78% QoQ
HCW Biologics's equity has plunged by 172% from the previous quarter and by 122% YoY
The company's debt has surged by 56% YoY and by 20% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.